🔎 Trials Near Me

Hem › Sickelcellssjukdom › Texas

Kliniska studier för Sickelcellssjukdom i Texas

11 studier för Sickelcellssjukdom söker deltagare vid platser i Texas.

Städer i Texas

Officiell studietext (engelska)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Texas Childrens Cancer and Hematology Center, Houston
  • U of TX Health Science Ct, Houston
RekryterarFas 3
Ålder 12 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Texas Children's Hospital_Houston, Houston
  • UT Health University of Texas, Houston
RekryterarFas 3
Ålder 2 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • UT Health University of Texas, Houston
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • UT Health Science Center, Houston
RekryterarFas 1/2Friska volontärer välkomna
Ålder 12 till 55 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06546670

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Blood and Cancer Center of Central Texas, Austin
  • North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
  • North Texas Comprehensive Hemophilia Treatment Center, Dallas
  • och 3 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • Baylor College of Medicine- Site Number : 8400055, Houston
RekryterarFas 3
Ålder 10 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT06975865

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Texas Children's Hopsital (NT-DMT), Houston
  • Texas Children's Hospital (MRD-HCT), Houston
  • UT San Antonio (NT-DMT), San Antonio
RekryterarObservationsstudie
Ålder 3 till 20 · Alla kön · Uppdaterad 4 juni 2026 · NCT06941389

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

  • Site # 8400004, Houston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 15 apr. 2026 · NCT07247188

Sickle Cell Kidney Biorepository

  • Parkland Memorial Hospital, Dallas
  • University of Texas Southwestern Medical Center, Dallas
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 13 apr. 2026 · NCT07064174

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • Baylor College of Medicine, Houston
RekryterarFas 2
Ålder 15 till 40 · Alla kön · Uppdaterad 13 mars 2026 · NCT06260891

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Texas at Houston, Houston
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 22 juni 2025 · NCT06385886

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.